A hormone-free male birth control pill called YCT-529 has successfully passed its initial safety test in humans, showing no significant side effects in a small trial, and is now moving into larger studies to evaluate its safety and effectiveness in preventing sperm production and offering a new contraceptive option for men.
A hormone-free male birth control pill called YCT-529 has successfully passed its initial safety test in humans, showing no significant side effects and paving the way for larger trials to assess its safety and effectiveness in preventing sperm production.
Doctors recommend several menopause supplements that have shown promising results in relieving symptoms such as hot flashes, night sweats, and mood swings. Bonafide Relizen, Nature's Way Remifemin, Metagenics Estrovera, One a Day Women's Menopause Multivitamin, and Hum Fan Club are among the top-rated supplements. These products contain ingredients like Swedish flower pollen extract, black cohosh, soy isoflavones, and probiotics, which have been clinically studied and shown to reduce menopausal symptoms. Additionally, Nutrafol Women's Balance Hair Growth Supplement and Gaia Herbs Women's Balance are recommended for combating hair thinning and hormonal balance, respectively. Thorne Research Meta-Balance is suggested for addressing brain fog. When choosing a menopause supplement, it is important to consider ingredients, third-party testing, and clinical studies.
The US FDA has approved a hormone-free drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during menopause. The drug works by targeting the brain's temperature control center to decrease both the frequency and intensity of hot flashes in women. Prior to the FDA's approval of fezolinetant, the main treatment options for hot flashes related to menopause were hormone replacement therapy (HRT) and some types of antidepressants. Veozah is a once-a-day pill and is promising for women who cannot take hormone treatment because of other underlying health concerns.